A new cannabinoid receptor 1 selective agonist evading the 2021 'China ban': ADB-FUBIATA.
Sign Up to like & getrecommendations! Published in 2022 at "Drug testing and analysis"
DOI: 10.1002/dta.3285
Abstract: Following the class-wide ban of synthetic cannabinoid receptor agonists (SCRAs) in China, SCRAs carrying new core and linker structures, aimed at circumventing the recent Chinese generic legislation, have appeared on the recreational drug market. A… read more here.
Keywords: adb; cannabinoid receptor; adb fubiata; ban ... See more keywords